Angiotensin-(1–7) Inhibitory Mechanism of Norepinephrine Release in Hypertensive Rats

  • Mariela M. Gironacci
    From the Departamento de Química Biológica, Instituto de Química y Fisicoquímica Biológicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.
  • María S. Valera
    From the Departamento de Química Biológica, Instituto de Química y Fisicoquímica Biológicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.
  • Irene Yujnovsky
    From the Departamento de Química Biológica, Instituto de Química y Fisicoquímica Biológicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.
  • Clara Peña
    From the Departamento de Química Biológica, Instituto de Química y Fisicoquímica Biológicas, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.

Description

<jats:p> Release of norepinephrine (NE) by the hypothalamic nuclei may contribute to regulation of sympathetic nervous system (SNS) activity. Angiotensin-(1–7) [Ang-(1–7)] has an antihypertensive effect and may decrease SNS activity. We tested the hypothesis that Ang-(1–7) inhibits the release of NE in hypothalami, via the Ang-(1–7) and angiotensin II type 2 (AT <jats:sub>2</jats:sub> ) receptors, acting through a bradykinin (BK)/NO-dependent mechanism. Hypothalami from normotensive controls and spontaneously hypertensive rats (SHR) were isolated and endogenous NE stores labeled by incubating the tissues with [ <jats:sup>3</jats:sup> H]NE. [ <jats:sup>3</jats:sup> H]NE release from the hypothalami was stimulated by KCl in the presence or absence of Ang-(1–7) alone or combined with various antagonists and inhibitors. Ang-(1–7) significantly attenuated K <jats:sup>+</jats:sup> -induced NE release by hypothalami from normotensive rats but was more potent in SHR. The Ang-(1–7) receptor antagonist [ <jats:sc>d</jats:sc> -Ala <jats:sup>7</jats:sup> ]Ang-(1–7), the AT <jats:sub>2</jats:sub> receptor antagonist PD 123319, and the BK B <jats:sub>2</jats:sub> receptor antagonist icatibant all blocked the inhibitory effect of Ang-(1–7) on K <jats:sup>+</jats:sup> -stimulated NE release in SHR. The inhibitory effect of Ang-(1–7) disappeared in the presence of the NO synthase inhibitor <jats:italic>N</jats:italic> <jats:sup>G</jats:sup> -nitro- <jats:sc>l</jats:sc> -arginine methyl ester and was restored by the precursor of NO, <jats:sc>l</jats:sc> -arginine. The diminished NE release caused by Ang-(1–7) was blocked by a soluble guanylyl cyclase inhibitor as well as by a cGMP-dependent protein kinase (PKG). We concluded that Ang-(1–7) decreases NE release from the hypothalamus via the Ang-(1–7) or AT <jats:sub>2</jats:sub> receptors, acting through a BK/NO-mediated mechanism that stimulates cGMP/PKG signaling. In this way, Ang-(1–7) may decrease SNS activity and exert an antihypertensive effect. </jats:p>

Journal

  • Hypertension

    Hypertension 44 (5), 783-787, 2004-11

    Ovid Technologies (Wolters Kluwer Health)

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top